secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001193125-23-194657
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE stockholders approve 1-for-100 reverse stock split effective July 27 to maintain Nasdaq listing
--------------------------------------------------------------------------------

- Reverse split ratio of 1:100; reduces outstanding shares from ~104M to ~1.04M.
- Effective 11:59 p.m. ET on July 27, 2023; split-adjusted trading begins July 28.
- Purpose: raise per-share bid price above $1.00 to meet Nasdaq listing requirement.
- No fractional shares issued; Computershare will aggregate and sell fractions, distributing net proceeds pro rata.
- No change to authorized shares; exercise prices and shares of equity awards/warrants adjusted proportionally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000119312523194657/0001193125-23-194657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000119312523194657/d540125d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-194657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer